Up to 20% of patients with OPA1 disease-causing variants develop other systemic symptoms, such as sensorineural hearing loss, progressive external ophthalmoplegia, ataxia, or peripheral neuropathy, which usually follow ocular symptoms are collectively called the ADOA plus syndrome [28,29,30]. Here, OPA1 is linked to peripheral neuropathy.